{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T01:49:47Z","timestamp":1791078587811,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research Bulletin"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.brainresbull.2006.03.013","type":"journal-article","created":{"date-parts":[[2006,4,19]],"date-time":"2006-04-19T13:42:46Z","timestamp":1145454166000},"page":"669-679","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Calcineurin inhibitors cause an acceleration of the neurological phenotype in a mouse transgenic for the human Huntington's disease mutation"],"prefix":"10.1016","volume":"69","author":[{"given":"David","family":"Hern\u00e1ndez-Espinosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Jennifer Morton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainresbull.2006.03.013_bib1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.brainres.2005.08.008","article-title":"Decreased activity and increased aggregation of brain calcineurin during aging","volume":"1059","author":"Agbas","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.brainresbull.2006.03.013_bib2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1046\/j.1365-2613.1999.00128.x","article-title":"Cyclophilins and their possible role in the stress response","volume":"80","author":"Andreeva","year":"1999","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.brainresbull.2006.03.013_bib3","series-title":"Huntington's Disease","author":"Bates","year":"2002"},{"key":"10.1016\/j.brainresbull.2006.03.013_bib4","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1111\/j.1471-4159.1990.tb03128.x","article-title":"Permeability of the blood\u2013brain barrier to the immunosuppressive cyclic peptide cyclosporin A","volume":"55","author":"Begley","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainresbull.2006.03.013_bib5","doi-asserted-by":"crossref","first-page":"6809","DOI":"10.1073\/pnas.120166397","article-title":"Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice","volume":"97","author":"Bibb","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"Pt 2","key":"10.1016\/j.brainresbull.2006.03.013_bib6","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1113\/jphysiol.2004.066563","article-title":"GABAB receptor activation inhibits exocytosis in rat pancreatic beta-cells by G-protein-dependent activation of calcineurin","volume":"559","author":"Braun","year":"2004","journal-title":"Physiology"},{"key":"10.1016\/j.brainresbull.2006.03.013_bib7","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1023\/B:NERE.0000014824.04728.dd","article-title":"The energetics of Huntington's disease","volume":"29","author":"Browne","year":"2004","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.brainresbull.2006.03.013_bib8","doi-asserted-by":"crossref","first-page":"6939","DOI":"10.1523\/JNEUROSCI.17-18-06939.1997","article-title":"Neuroprotective actions of FK506 in experimental stroke: in vivo evidence against an antiexcitotoxic mechanism","volume":"17","author":"Butcher","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2006.03.013_bib9","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00007890-200107150-00010","article-title":"Combined immunosuppression of mycophenolate mofetil and FK506 for myoblast transplantation in mdx mice","volume":"72","author":"Camirand","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.brainresbull.2006.03.013_bib10","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","article-title":"Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation","volume":"19","author":"Carter","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2006.03.013_bib11","doi-asserted-by":"crossref","first-page":"15794","DOI":"10.1073\/pnas.2536696100","article-title":"The Drosophila homolog of Down's syndrome critical region 1 gene regulates learning: implications for mental retardation","volume":"100","author":"Chang","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.brainresbull.2006.03.013_bib12","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2174\/1381612805666230110214512","article-title":"An overview of cyclophosphamide development and clinical applications","volume":"5","author":"Colvin","year":"1999","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.brainresbull.2006.03.013_bib13","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0166-2236(98)01304-6","article-title":"Cellular mechanisms of cerebellar LTD","volume":"21","author":"Daniel","year":"1998","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.brainresbull.2006.03.013_bib14","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0306-4522(94)90389-1","article-title":"The immunophilins, FK506 binding protein and cyclophilin, are discretely localized in the brain: relationship to calcineurin","volume":"62","author":"Dawson","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainresbull.2006.03.013_bib15","doi-asserted-by":"crossref","first-page":"38787","DOI":"10.1074\/jbc.M102829200","article-title":"Chronic overexpression of the calcineurin inhibitory gene DSCR1 (Adapt78) is associated with Alzheimer's disease","volume":"276","author":"Ermak","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainresbull.2006.03.013_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/1521654031000066820","article-title":"DSCR1 (Adapt78)\u2014a Janus gene providing stress protection but causing Alzheimer's disease?","volume":"55","author":"Ermak","year":"2003","journal-title":"IUBMB Life"},{"key":"10.1016\/j.brainresbull.2006.03.013_bib17","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1523\/JNEUROSCI.21-11-04066.2001","article-title":"Calcineurin links Ca2+ dysregulation with brain aging","volume":"21","author":"Foster","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2006.03.013_bib18","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.1523\/JNEUROSCI.18-14-05151.1998","article-title":"Cyclosporine A, but not FK 506, protects mitochondria and neurons against hypoglycemic damage and implicates the mitochondrial permeability transition in cell death","volume":"18","author":"Friberg","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2006.03.013_bib19","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1093\/hmg\/9.11.1681","article-title":"DSCR1, overexpressed in Down's syndrome, is an inhibitor of calcineurin-mediated signaling pathways","volume":"9","author":"Fuentes","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.brainresbull.2006.03.013_bib20","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1046\/j.1460-9568.2002.02235.x","article-title":"Calcineurin regulates induction of late phase of cerebellar long-term depression in rat cultured Purkinje neurons","volume":"16","author":"Fujii","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.brainresbull.2006.03.013_bib21","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0006-8993(02)04151-3","article-title":"Neuroprotective action of tacrolimus (FK506) in focal and global cerebral ischemia in rodents: dose dependency, therapeutic time window and long-term efficacy","volume":"965","author":"Furuichi","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.brainresbull.2006.03.013_bib22","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1523\/JNEUROSCI.22-12-04842.2002","article-title":"Calpain activation in Huntington's disease","volume":"22","author":"Gafni","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2006.03.013_bib23","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1517\/13543784.9.10.2331","article-title":"Neuroimmunophilin ligands: evaluation of their therapeutic potential for the treatment of neurological disorders","volume":"9","author":"Gold","year":"2000","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.brainresbull.2006.03.013_bib24","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.bbrc.2003.09.002","article-title":"Calcineurin regulation of neuronal plasticity","volume":"311","author":"Groth","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.brainresbull.2006.03.013_bib25","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/343369a0","article-title":"Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slices","volume":"343","author":"Halpain","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.brainresbull.2006.03.013_bib26","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1006\/bbrc.2001.4968","article-title":"Up-regulation of calcineurin Abeta mRNA in the Alzheimer's disease brain: assessment by cDNA microarray","volume":"284","author":"Hata","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.brainresbull.2006.03.013_bib27","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1046\/j.1471-4159.2002.00804.x","article-title":"The role of dopamine in motor symptoms in the R6\/2 transgenic mouse model of Huntington's disease","volume":"81","author":"Hickey","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainresbull.2006.03.013_bib28","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/hmg\/ddl013","article-title":"Regional and cellular gene expression changes in human Huntington's disease brain","volume":"15","author":"Hodges","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.brainresbull.2006.03.013_bib29","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s00221-005-2357-z","article-title":"Atypical diabetes associated with inclusion formation in the R6\/2 mouse model of Huntington's disease is not improved by treatment with hypoglycaemic agents","volume":"166","author":"Hunt","year":"2005","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.brainresbull.2006.03.013_bib30","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2337\/diabetes.48.3.649","article-title":"Mice transgenic for an expanded CAG repeat in the Huntington's disease gene develop diabetes","volume":"48","author":"Hurlbert","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.brainresbull.2006.03.013_bib31","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1432-1033.1983.tb07357.x","article-title":"The protein phosphatases involved in cellular regulation. 1. Classification and substrate specificities","volume":"132","author":"Ingebritsen","year":"1983","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.brainresbull.2006.03.013_bib32","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0161-5890(97)00054-0","article-title":"Distinct tissue and cellular distribution of two major isoforms of calcineurin","volume":"34","author":"Jiang","year":"1997","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.brainresbull.2006.03.013_bib33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1582-4934.2004.tb00259.x","article-title":"Molecular mechanisms of neuroprotective action of immunosuppressants\u2014facts and hypotheses","volume":"8","author":"Kaminska","year":"2004","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.brainresbull.2006.03.013_bib34","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1098\/rstb.1999.0542","article-title":"The past, the future and the biology of memory storage","volume":"354","author":"Kandel","year":"1999","journal-title":"Phil. Trans. Roy. Soc. Lond., Ser. B: Biol. Sci."},{"key":"10.1016\/j.brainresbull.2006.03.013_bib35","first-page":"435","article-title":"Bone marrow morphology during haematopoietic stem cell mobilisation with cyclophosphamide in mice","volume":"62","author":"Karbicka","year":"2003","journal-title":"Folia Morphol. (Warsz)"},{"key":"10.1016\/j.brainresbull.2006.03.013_bib36","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1210\/mend.15.10.0702","article-title":"Regulation of insulin gene transcription by a Ca(2+)-responsive pathway involving calcineurin and nuclear factor of activated T cells","volume":"15","author":"Lawrence","year":"2001","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.brainresbull.2006.03.013_bib37","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2337\/diabetes.51.3.691","article-title":"NFAT regulates insulin gene promoter activity in response to synergistic pathways induced by glucose and glucagon-like peptide-1","volume":"51","author":"Lawrence","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.brainresbull.2006.03.013_bib38","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1006\/exnr.2000.7534","article-title":"Selective changes of calcineurin (protein phosphatase 2B) activity in Alzheimer's disease cerebral cortex","volume":"167","author":"Lian","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainresbull.2006.03.013_bib39","doi-asserted-by":"crossref","first-page":"10428","DOI":"10.1523\/JNEUROSCI.19-23-10428.1999","article-title":"Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation","volume":"19","author":"Lione","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2006.03.013_bib40","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/hmg\/9.9.1259","article-title":"Decreased expression of striatal signaling genes in a mouse model of Huntington's disease","volume":"9","author":"Luthi-Carter","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.brainresbull.2006.03.013_bib41","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.brainresbull.2006.03.013_bib42","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1093\/hmg\/9.14.2197","article-title":"CREB-binding protein sequestration by expanded polyglutamine","volume":"9","author":"McCampbell","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.brainresbull.2006.03.013_bib43","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1111\/j.1471-4159.1992.tb10056.x","article-title":"Regional and temporal alterations in Ca2+\/calmodulin-dependent protein kinase II and calcineurin in the hippocampus of rat brain after transient forebrain ischemia","volume":"58","author":"Morioka","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainresbull.2006.03.013_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0301-0082(98)00073-2","article-title":"Potential role of calcineurin for brain ischemia and traumatic injury","volume":"58","author":"Morioka","year":"1999","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.brainresbull.2006.03.013_bib45","doi-asserted-by":"crossref","first-page":"23817","DOI":"10.1016\/S0021-9258(17)31588-0","article-title":"Calcineurin-mediated protein dephosphorylation in brain nerve terminals regulates the release of glutamate","volume":"269","author":"Nichols","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainresbull.2006.03.013_bib46","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1046\/j.1471-4159.1999.0722015.x","article-title":"Role of calcineurin and protein phosphatase 2A in the regulation of DARPP-32 dephosphorylation in neostriatal neurons","volume":"72","author":"Nishi","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainresbull.2006.03.013_bib47","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1126\/science.1056784","article-title":"Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity","volume":"291","author":"Nucifora","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.brainresbull.2006.03.013_bib48","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2174\/1568007033482652","article-title":"Therapeutic implications for immunophilin ligands in the treatment of neurodegenerative diseases","volume":"2","author":"Pong","year":"2003","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"key":"10.1016\/j.brainresbull.2006.03.013_bib49","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/ng1362","article-title":"Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease","volume":"36","author":"Ravikumar","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.brainresbull.2006.03.013_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/oxfordjournals.jbchem.a003063","article-title":"Calcineurin as a multifunctional regulator","volume":"131","author":"Shibasaki","year":"2002","journal-title":"J. Biochem. (Tokyo)"},{"key":"10.1016\/j.brainresbull.2006.03.013_bib51","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0022-510X(02)00304-0","article-title":"Protective effect of systemic treatment with cyclosporine A after global ischemia in rats","volume":"203\u2013204","author":"Sinigaglia-Coimbra","year":"2002","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.brainresbull.2006.03.013_bib52","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nm0195-32","article-title":"Immunophilins and the nervous system","volume":"1","author":"Snyder","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/j.brainresbull.2006.03.013_bib53","first-page":"21","article-title":"Neural actions of immunophilin ligands","volume":"19","author":"Snyder","year":"1998","journal-title":"TIPS"},{"key":"10.1016\/j.brainresbull.2006.03.013_bib54","doi-asserted-by":"crossref","first-page":"6762","DOI":"10.1073\/pnas.100110097","article-title":"The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription","volume":"97","author":"Steffan","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.brainresbull.2006.03.013_bib55","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0074-7742(08)60693-5","article-title":"GABAA receptors control the excitability of neuronal populations","volume":"33","author":"Stelzer","year":"1992","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.brainresbull.2006.03.013_bib56","first-page":"469","article-title":"Distribution and activity of calcineurin in rat tissues. Evidence for post-transcriptional regulation of testis-specific calcineurin B","volume":"230","author":"Su","year":"1995","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.brainresbull.2006.03.013_bib57","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1021\/bi00406a059","article-title":"Activation of a calmodulin-dependent phosphatase by a Ca2+ dependent protease","volume":"27","author":"Tallant","year":"1988","journal-title":"Biochemistry"},{"key":"10.1016\/j.brainresbull.2006.03.013_bib58","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1097\/00001756-200011270-00032","article-title":"N-Acetylaspartate and DARPP-32 levels decrease in the corpus striatum of Huntington's disease mice","volume":"11","author":"van Dellen","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.brainresbull.2006.03.013_bib59","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/35081514","article-title":"Roles of serine\/threonine phosphatases in hippocampal synaptic plasticity","volume":"2","author":"Winder","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.brainresbull.2006.03.013_bib60","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.1074\/jbc.M309767200","article-title":"Critical role of calpain-mediated cleavage of calcineurin in excitotoxic neurodegeneration","volume":"279","author":"Wu","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainresbull.2006.03.013_bib61","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/hmg\/10.17.1829","article-title":"Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease","volume":"10","author":"Wyttenbach","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.brainresbull.2006.03.013_bib62","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0306-4522(92)90225-Q","article-title":"Alteration in the immunoreactivity of the calcineurin subunits after ischemic hippocampal damage","volume":"49","author":"Yamasaki","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainresbull.2006.03.013_bib63","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0092-8674(01)00585-2","article-title":"Forebrain-specific calcineurin knockout selectively impairs bidirectional synaptic plasticity and working\/episodic-like memory","volume":"107","author":"Zeng","year":"2001","journal-title":"Cell"},{"issue":"Suppl","key":"10.1016\/j.brainresbull.2006.03.013_bib64","first-page":"129","article-title":"In vivo brain microdialysis as a tool in studies of neuroprotective effects of cyclosporine A in acute excitotoxicity","volume":"57","author":"Zieminska","year":"2000","journal-title":"Acta Pol. Pharm."}],"container-title":["Brain Research Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923006001122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923006001122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T19:57:49Z","timestamp":1759780669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0361923006001122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":64,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0361923006001122"],"URL":"https:\/\/doi.org\/10.1016\/j.brainresbull.2006.03.013","relation":{},"ISSN":["0361-9230"],"issn-type":[{"value":"0361-9230","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Calcineurin inhibitors cause an acceleration of the neurological phenotype in a mouse transgenic for the human Huntington's disease mutation","name":"articletitle","label":"Article Title"},{"value":"Brain Research Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainresbull.2006.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}